Larionova, Irina,
Iamshchikov, Pavel,
Kazakova, Anna,
Rakina, Militsa,
Menyalo, Maxim,
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Pavlov, Valentin,
Villert, Alisa,
Kolomiets, Larisa,
Kzhyshkowska, Julia (2025) -line treatment with platinum-
based chemotherapy. At present, numerous clinical trials are being conducted
etiopathogenesis owing to pathological activation of transposable elements complementary to the
sequencesMustafin, R.N.,
Bermisheva, M.A.,
Karunas, A.S.,
Akhmetshin, A.A.,
Monakhova, A.S.,
Khusnutdinova, E.K. (2025) of Bashkortostan,
sequencing the NF1 gene in their DNA samples as well as whole genome
sequencing using the WGS
Blinov, Andrey,
Nagdalian, Andrey,
Rzhepakovsky, Igor,
Rekhman, Zafar,
Askerova, Alina,
Agzamov, Vadim,
Kayumov, Umedzhon,
Tairov, Dilshod,
Ibrahimov, Sobirzhon,
Sayahov, Ilgiz (2025) as stabilizing agents: chitosan, methylcellulose, hydroxyethyl cellulose and hyaluronic
acid. The experimental
retroelements using micro-ribonucleic
acids (microRNAs) derived from transposable elements has been proposed
determination of glial fibrillary
acidic protein (GFAP) and anti-apoptotic B-cell lymphoma-2 protein (Bcl-2